the study was repeated 30 min after intravenous administration of dihydralazine ( 0.1 mg/kg body weight ) in 14 subjects ( group a ) and during continuous infusion of the angiotensin ii blocking agent saralasin ( 5 micrograms/kg . min ) in 10 subjects ( group b ) .
C0003009
angiotensin ii
C0036193
saralasin